RxDoctor Payments Data

Robert Dahmes, MD

Psychiatry · New Orleans, LANPI 1992767537

Payments from drug & device makers

$511in general payments, 2019–2025

Across 32 payments — averaging $15.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$157
  • Johnson & Johnson$120
  • Alkermes, Inc.$76
  • Ironshore Pharmaceuticals Inc.$37
  • Otsuka America Pharmaceutical, Inc.$32
  • Takeda Pharmaceuticals U.S.A., Inc.$30
  • plus $59 from 3 others

What the payments were for

  • Food & beverage$511100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$511 in reported general payments places this provider in the 45th percentile of 474 psychiatry providers in Louisiana.

See all psychiatry providers in Louisiana

Medicare billing

Part B allowed, 2024
$6,885
Medicare patients
14
Services billed
91

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl11$18,143
VyvanseLisdexamfetamine Dimesylate23$12,124
Dextroamphetamine Sulfate ErDextroamphetamine Sulfate17$5,854
Clorazepate Dipotassium11$2,249
Clonazepam246$2,166
Aripiprazole38$2,053
Bupropion XlBupropion Hcl71$1,235
Desvenlafaxine Succinate ErDesvenlafaxine Succinate13$1,144
Venlafaxine Hcl ErVenlafaxine Hcl55$812
Quetiapine Fumarate41$767
Escitalopram Oxalate62$632
Memantine Hcl ErMemantine Hcl13$489
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine18$412
Quetiapine Fumarate ErQuetiapine Fumarate15$360
Mirtazapine25$306

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$157$18,14311 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$30$12,12423 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 474 psychiatry providers in Louisiana.

Other psychiatry in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →